Benzinga | Nov 9, 2020 07:17AM EST

Avadel Pharmaceuticals Q3 EPS $(0.20) Beats $(0.25) Estimate

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.25) by 20 percent. This is a 16.67 percent increase over losses of $(0.24) per share from the same period last year.